Healthtech startup Breathe Well-being announced on Thursday it has raised Rs 50 crore in a funding round co-led by 3One4 Capital, Accel and General Catalyst. FounderBank Capital and Supermorpheus also participated in the round.

The company will use the funds to strengthen its coaching academy, expand the core team, and scale up the technology platform to enhance customer experience, it said in a statement.

Breathe Well-being offers an alternative to medicines to prevent, manage and reverse type 2 diabetes.

The startup was founded in Gurgaon by Rohan Verma and Aditya Kaicker in 2020.

Verma, cofounder and CEO, Breathe Well-being, said, “India is the diabetes capital of the world and we are on a mission to change that. Our aim is a diabetes mukt bharat (diabetes-free India) with the aim of reversing diabetes for one million Indians by 2025 and we are well on track to achieving that goal."

Breathe Well-being uses a personalised coach-driven, community-first approach through interactive gamification to help people with type 2 diabetes reduce HbA1c, lose weight and reduce medication dependability.

Discover the stories of your interest

Radhika Ananth, vice president, Accel, said: “We have been impressed by how quickly Breathe Well-being is becoming a household name for type 2 diabetes and pre-diabetes reversal across tier 2 and 3 cities of India. Accel continues to back them in their vision of building a diabetes mukt bharat.”The startup claims that its programme has a "proven outcome with over 95% participants showing an average reduction of 1.5% in their HbA1c levels, over 98% participants eliminating medication and experiencing an average weight loss of 5.5 kg over the course of the programme, which is recognised by the American Diabetes Association (ADA)".

Kaicker, cofounder and COO, Breathe Well-being, said, “We have seen more than 90% of participants sustain their results beyond 24 months into the programme. This is a big indicator of how engaging our entire plan is and people’s active willingness to get off the diabetes medication.”

Stay on top of technology and startup news that matters. Subscribe to our daily newsletter for the latest and must-read tech news, delivered straight to your inbox.

Source link